Patient Demographic | All (N = 50) | Betadine (N = 25) | Control (N = 25) | p value |
---|---|---|---|---|
Age (years) | 69.5 (55.7–86) | 73 (55-87.5) | 69 (55.5–83) | 0.712 |
Sex (M/F) (%) | 29 (58%)/21 (42%) | 14 (58.3%)/10 (41.7%) | 15 (57.7%)/11 (42.3%) | 0.963 |
BMI | 19.99 (17.89–23.23) | 18.98 (17.38–23.06) | 21.30 (18.41–23.82) | 0.443 |
Head and neck cancer (%) | 7 (14%) | 5 (20%) | 2 (8%) | 0.417 |
CVA (%) | 17 (34%) | 6 (24%) | 11 (44%) | 0.232 |
HTN (%) | 28 (56%) | 14 (56%) | 14 (56%) | 1.000 |
DM (%) | 14 (28%) | 6 (24%) | 8 (30.8%) | 0.754 |
Dementia (%) | 17 (34%) | 9 (36%) | 8 (32%) | 0.765 |
ALS (%) | 15 (30%) | 6 (24%) | 9 (36%) | 0.355 |
Biochemistry | ||||
Albumin-before (g/dl) | 3.7 (3.3–4.1) | 3.7 (3.0–4.0) | 3.7 (3.3–4.1) | 0.690 |
WBC-before (cumm) | 6.8 (5.8–8.4) | 6.3 (5.4–8.3) | 7.5 (6.1–8.5) | 0.252 |
N/L ratio-before | 3.2 (2.6–4.4) | 3.2 (2.2–4.3) | 3.3 (2.6–4.6) | 0.778 |
CRP-before (mg/dl) | 0.27 (0.09–1.07) | 0.27 (0.09–1.15) | 0.23 (0.09–1.24) | 0.854 |
WBC-after (cumm) | 9.0 (6.8–10.6) | 8.3 (6.2–10.2) | 9.3 (8.1–11.5) | 0.099 |
N/L ratio-after | 5.5 (3.5–7.4) | 4.6 (3.1–6.4) | 6.3 (3.6–8.1) | 0.052 |
CRP-after (mg/dl) | 2.64 (1.06–5.01) | 1.91 (0.79–3.14) | 3.62 (1.52–5.44) | 0.076 |
Delta WBC (cumm) | 1.6 (0.2–3.7) | 1.3 (-0.1-3.0) | 1.8 (0.4–4.6) | 0.225 |
Delta N/L ratio | 1.4 (0.4–3.8) | 1.2 (0-2.7) | 3.1 (0.7–4.4) | 0.047 |
Delta CRP (mg/dl) | 1.75 (0.77–3.01) | 1.16 (0.51-2.00) | 2.68 (1.36–4.1) | 0.009 |
Total time (min) | 20.5 (18-27.3) | 20 (18–28) | 21 (17–27) | 0.869 |
PEG procedure time (min) | 9 (6–10) | 9 (6.5–11) | 8 (6-9.5) | 0.068 |
Fever (%) | 3 (6%) | 0 | 3 (12%) | 0.235 |
Total peristomal wound infection (%) | 10 (20%) | 6 (24%) | 4 (16%) | 0.725 |
Total pneumonia (%) | 5 (10%) | 1 (4%) | 4 (16%) | 0.349 |
Total stomal leakage (%) | 8 (16%) | 5 (20%) | 3 (12%) | 0.702 |
All-cause infection (%) | 13 (26%) | 6 (24%) | 7 (28%) | 0.725 |
Admission days | 6.5 (4–11) | 7 (4-10.5) | 6 (4–13) | 0.770 |